Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-02 · accession 0001209191-23-006994 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-03 | 2023-02-02 | ADPT | HERSHBERG ROBERT | Dir | M - OptEx | $0.45 | +53.0K | 61.2K | +647% | +$23.9K |
| D | 2023-02-03 | 2023-02-02 | ADPT | HERSHBERG ROBERT | Dir | M - OptEx | $0.00 | -53.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-02 | M | A | 53,000 | $0.45 | 61,193 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-02-02 | M | D | 53,000 | $0.00 | 0 | D | $0.45 · — to 2023-02-04 | 53,000 Common Stock | (F1) The option is fully vested and exercisable. |